Griffith University Institute for Biomedicine and Glycomics Revenue and Competitors
Employee Data
- Griffith University Institute for Biomedicine and Glycomics has 90 Employees.
- Griffith University Institute for Biomedicine and Glycomics grew their employee count by 27% last year.
Griffith University Institute for Biomedicine and Glycomics's People
Name | Title | Email/Phone |
---|
Griffith University Institute for Biomedicine and Glycomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 82 | 19% | N/A | N/A |
#2 | N/A | 212 | 5% | N/A | N/A |
#3 | N/A | 68 | 31% | N/A | N/A |
#4 | N/A | 72 | 20% | N/A | N/A |
#5 | N/A | 4 | 0% | N/A | N/A |
#6 | N/A | 858 | 4% | N/A | N/A |
#7 | N/A | 61 | 20% | N/A | N/A |
#8 | N/A | 52 | 49% | N/A | N/A |
#9 | N/A | 63 | 24% | N/A | N/A |
#10 | N/A | 90 | 27% | N/A | N/A |
What Is Griffith University Institute for Biomedicine and Glycomics?
The Institute for Biomedicine and Glycomics has combined the expertise of its founding institutes — the Institute for Glycomics, Griffith Institute for Drug Discovery, and the biomedical teams from within the Menzies Health Institute Queensland. Each of the three founding institutes have strong reputations for research excellence in their own right, together they will be formidable. Griffith biomedical researchers lead the world in specific disciplinary areas, and work on challenges that affect communities around the world including some of the poorest and most disenfranchised. By investing in this new Institute for Biomedicine and Glycomics, we position ourselves to support our world-leading teams to achieve even greater successes.
keywords:N/AN/A
Total Funding
90
Number of Employees
N/A
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.3M | 93 | 27% | N/A |
#2 | $24.4M | 116 | 8% | N/A |
#3 | $39M | 120 | 9% | N/A |
#4 | $32.3M | 122 | 8% | N/A |
#5 | $32.1M | 128 | 8% | N/A |